November 15, 2018
Drugmakers increasingly are adopting a new marketing strategy to promote their products on social media—but some experts say the rise of the so-called "patient influencers" raises ethical concerns.
November 14, 2018
Many of the antibiotics people use today could become ineffective within three decades, and experts predict there will be few replacements unless major changes are made to the research and development process.
FDA says Sandoz has voluntarily recalled one lot of Hyzaar, which treats high blood pressure, because an active pharmaceutical ingredient in the tablets from the lot tested positive for an organic chemical classified as a probable human carcinogen.
November 13, 2018
The American Heart Association's and the American College of Cardiology's new guidelines for treating high cholesterol emphasize a more personalized approach to treatment, updating the controversial guidelines released by the organizations in 2013.
November 12, 2018
Prescription drug costs, the Affordable Care Act, and "Medicare-for-All" are among the key policy issues leaders of the 116th Congress likely will address.
November 8, 2018
CVS Pharmacy is piloting an Amazon Prime-like membership program, called CarePass, that will include a $10 monthly store credit, a 20% discount on CVS-branded product, speedy free delivery of most prescription drugs, and more.
November 7, 2018
In Tuesday's midterm elections, Republicans expanded their Senate majority but lost control of the House—likely meaning the GOP effort to repeal the Affordable Care Act is dead, and giving Democrats new leverage to scrutinize President Trump's health policy choices.
Massachusetts voters rejected a controversial measure that would have allowed the state to set patient limits for nurses and voters, but three states voted to expand Medicaid. Explore these and other key initiatives on our interactive map.
Reps. Diana DeGette (D-Colo.) and Tom Reed (R-N.Y.), co-chairs of the Congressional Diabetes Caucus, in a report say payment incentives, outdated patent regulations, and other factors have allowed drugmakers to increase the price of insulin by nearly 300% from 2002 to 2013.
November 6, 2018
FDA has approved 23andMe's Personal Genome Service Pharmacogenetic Reports, which will provide information on how a patient's genetic variants could affect their response to particular drug classes—but the approval came with a few caveats.
The Advisory Board Company. All Rights Reserved.